Takeda, Lilly may face thousands of s...

Takeda, Lilly may face thousands of suits over Actos claims

There are 7 comments on the Indianapolis Business News story from Dec 1, 2011, titled Takeda, Lilly may face thousands of suits over Actos claims. In it, Indianapolis Business News reports that:

Takeda Pharmaceutical Co., Asia's biggest drugmaker, may face as many as 10,000 lawsuits in U.S. courts over allegations that its Actos diabetes drug causes bladder cancer, and a group of judges is preparing to decide where those suits should be consolidated.

Join the discussion below, or Read more at Indianapolis Business News.

“Watchtower Whistle-Blower”

Since: Dec 06

Bangor Maine USA

#1 Dec 1, 2011
Actos is produced by Takeda Industries and co-marketed by Eli Lilly.

Eli Lilly Zyprexa can *cause* diabetes.

I took Zyprexa a powerful Lilly schizophrenic drug for 4 years it was prescribed to me off-label for post traumatic stress disorder was ineffective costly and gave me diabetes.
Eli Lilly's #1 cash cow Zyprexa drug sale $40 billion dollars so far,has a ten times greater risk of causing type 2 diabetes over the non-user of Zyprexa. So,here we have a conflict of interest that this same company Eli Lilly also is a big profiteer of diabetes treatment.

(Actos works as an insulin *sensitizer*)
Sooooo,Eli Lilly pushes a drug (Zyprexa) that can cause diabetes.... then turn around sell you the drugs (Actos) to treat the diabetes that in turn can cause cancer!
What a terrible conflict of interest!
-- Daniel Haszard

FMI http://1url.com/0vi
Country Boy

Scottsville, NY

#2 Dec 2, 2011
I took Celexa for 3 years. I often wonder if that was the source of my type 2 problem.
I can't afford Actos the brand name at $8 per pill, so I order and take the generic version ( not available in the US) order thru an Canadaian pharmacy; $1 per pill.

New York, NY

#3 Dec 16, 2011
It is becoming apparent that the manufacturer is more interested in raising its profits that protecting its consumers. Not only is Actos said to cause bladder cancer but it also could cause congestive heart failure among its users. http://www.rotlaw.com/actos/

New York, NY

#4 Dec 16, 2011
Actos is well known worldwide to effectively treat Type 2 diabetes. To result in fatal injuries like bladder cancer or heart failure is a clear disadvantage of this drug. There are thousands of Actos lawsuits filed against its manufacturers; however physicians still continue to prescribe the drug despite major risks. http://www.rotlaw.com/actos/
Country Boy

Scottsville, NY

#5 Dec 16, 2011
I have researched and read the report that has started this whole mess with Actos. The increase in occurance of bladder cancer was insignificate; like 3 in 10000 to 9 in 10000. Not enough to warrant the problems caused by high BS from not taking the drug. I'll take my chances with Actos as the drug is very effective in controling my BS.

Since: May 12

Philadelphia, PA

#6 May 9, 2012
After the Avandia Scare, many people switched to Actos. Now, people who thought they were keeping themselves safe are findind out they may have been doing more harm than good. It's unfortunate. I work for a firm that has been investigating these instances of bladder cancer. http://www.anapolschwartz.com/practices/actos...

Since: Dec 12

Windermere, FL

#7 May 11, 2013
I think any Type 2 diabetes patient that has taken Actos and have developed bladder cancer or have had heart problems should file a Actos lawsuit for compensation. http://actoslawsuitsettlement2012.com

We can help victims with their Actos lawsuit and we do it on contingency so you only pay if we can get you a compensation from the manufacture



Tell me when this thread is updated:

Subscribe Now Add to my Tracker

Add your comments below

Characters left: 4000

Please note by submitting this form you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.

Healthcare Industry Discussions

Title Updated Last By Comments
News Despite $19 million salary, Mylan CEO failed to... (Sep '16) Mar 13 Seniors For Fairness 4
Options on Reducing the Deficit Mar 13 skd2138 1
Raising the Medicare Eligible Age Mar 13 MelissaB 1
News Regeneron Pharmaceuticals Inc (REGN) Given Aver... Mar 12 Ralph Petrillo 1
Facility Selection Research: Long-term Care Fac... Mar 5 ccyy 1
News Bashful? Buy the little blue pill online (May '13) Mar 4 Josel 15
News Sanofi : FDA to review Dupixent (dupilumab) as ... Mar 2 Ralph Petrillo 1